Phathom Pharmaceuticals, Inc. PHAT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
The official record: Phathom Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Phathom Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Phathom Pharmaceuticals, Inc.'s enterprise value?
- Phathom Pharmaceuticals, Inc. (PHAT) reported enterprise value of $860.85M in Q1 2026.
- How has Phathom Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s enterprise value increased by 101.2% year-over-year, from $427.87M to $860.85M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s enterprise value has grown at a 9.2% compound annual growth rate (CAGR), from $812.72M to $1.26B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.